WuXi Biologics | Sustainability & Chart

KYG970081173

Basic information on WuXi Biologics

Location: Cayman Islands

Industry: Manufacturing

Website

Impact Score

Description WuXi Biologics

Wuxi Biologics is a global open-access biologics technology platform offering end-to-end solutions to help organizations discover, develop, and manufacture biologics.

WuXi Biologics Sustainability Performance

Climate

17%

Renewable Energy

WuXi Biologics obtains 7,5% of its energy from renewable energies. Target value per method: min. 100%

Greenhouse Gas Emissions

WuXi Biologics emits 3,7 times its CO₂ budget of 64,894 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Supply Chain

Taking into account the entire supply chain, WuXi Biologics emits 5 times its CO₂ budget of 64,894 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Recycling and Recovery of Waste

WuXi Biologics recycles 8,9% of its waste. Target value per method: min. 75%

Society

60%

Union Formation and Collective Bargaining Power

WuXi Biologics issues 24% collective agreements. Target value per method: min. 80%

CEO Pay Ratio

CEO Dr. Zhisheng Chen earns 174 times the average salary of employees. Target value per method: max. 20 times

Employee Turnover Rate

WuXi Biologics has an employee turnover rate of 10%. Target value per method: max. 10%

Harassment and Discrimination at the Workplace

WuXi Biologics meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria

Gender

82%

Women on Board

WuXi Biologics has 30,8% women across its top leadership and supervisory bodies. Target value per method: min. 40%

Gender Pay Gap

WuXi Biologics has a gender pay gap of 5,7%. Target value per method: max. 3%

Women in Management

WuXi Biologics employs 41% female managers. Target value per method: min. 40%

Glass Ceiling

The proportion of women in senior management at WuXi Biologics is 89,1% of the proportion of women in the overall workforce. Target value per method: min. 90%

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

Renewable Energy

Greenhouse Gas Emissions

Supply Chain

Waste Recycling

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare WuXi Biologics with ...

WuXi Biologics

?

Impact Score

Climate

Society

Gender

17%

60%

82%

WuXi Biologics

?

Impact Score

Climate

Society

Gender

Sources of sustainability performance

Metric	Value	Unit	Year	PDF Name	PDF Page
CEO Pay Ratio
CEO salary	95 695	RMB'000	2025	2026042900764.pdf	173
Total wages paid	7 325 998	RMB’000	2025	2026042900764.pdf	168
CEO name	Dr. Zhisheng Chen		2025	2026042900764.pdf	38
Number of employees	13 352	people	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	77
Employee Turnover Rate
Employee turnover	10	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	131
Gender Pay Gap
Unadjusted gender pay gap	5,7	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	74
Glass Ceiling
Women in management	41	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	130
Women in workforce	46	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	74
Greenhouse Gas Emissions
Scope 1 emissions	44 125	tCO2e	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	125
Number of employees	13 352	people	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	77
Scope 2 emissions, location based	196 599	tCO2e	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	151
Harassment and Discrimination at the Workplace
Anti-discrimination policy	Yes		2025	WuXi-Biologics-Diversity-Equity-and-Inclusion-Policy.pdf	6
Confidentiality mechanisms	Yes		2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	37
Incident notification mechanism	Yes		2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	37
Retaliation safeguards	Yes		2025	WuXi-Biologics-Code-of-Business-ConductEthics-2024.pdf	41
Renewable Energy
Total renewable energy consumption	34 680 425	kWh	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	125
Total energy consumption	464 782	MWh	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	125
Supply Chain
Scope 3 emissions	84 738	tCO2e	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	125
Number of employees	13 352	people	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	77
Scope 2 emissions, location based	196 599	tCO2e	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	151
Scope 1 emissions	44 125	tCO2e	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	125
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage	24	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	129
Recycling and Recovery of Waste
Total waste generation	7 307,64	tonnes	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	126
Waste recycled	647,64	tonnes	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	126
Women on Board
Women on supervisory board	33,33	%	2025	2026042900764.pdf	89
Women on executive board	33	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	130
Executive board size	3	people	2025	2026042900764.pdf	42
Supervisory board size	10	people	2025	2026042900764.pdf	79
Women in Management
Women in management	41	%	2025	E_898490_WUXI-BIO_ESG2025_0429_1713_ESS.pdf	130

Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

Home Find Companies & ETFs Learn to invest Academy Glossary Our Method

Imprint Privacy Policy GTC FAQContact Us

© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev